Flagship explainer
How PHARMA-BIO SERV, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $9M | 100% |
| |
| Cost of revenue | $6.1M | 68% |
|
| $2.9M | 32% |
| |
| −$637662 | −7% |
| |
| Income before tax | −$94260 | −1% |
|
| Income tax | $6203 | 0% |
|
| −$100463 | −1% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001654954-26-000710